Earnings History Data for Calithera Biosciences, Inc. (CALA) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Calithera Biosciences, Inc.

Calithera Biosciences, Inc. is a clinical-stage pharmaceutical company. It is focused on discovering and developing small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer. The Company's lead product candidate includes CB-839 which is in three Phase I clinical trials for the treatment of patients with solid tumors, leukemias, lymphomas, and multiple myeloma. Calithera Biosciences, Inc. is headquartered in South San Francisco, California.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
14-11-2022	AH	4:05 PM ET (Nov 14)	CALA	Calithera Biosciences, Inc.	12.41	-2.01	-1.99	3.00	Calithera Biosciences reports Q3 results [11/14/2022 4:23 PM]	2.37	-0.45 (-15.96%)	2.68	-0.14 (-4.96%)	2.15 - 21.40	181,914	20,000	773
Calithera Biosciences reports Q3 results [11/14/2022 4:23 PM] Calithera Biosciences Reports Third Quarter 2022 Financial Results and Business Update [Nov-14-22 04:05PM]
15-08-2022	AH	4:05 PM ET (Aug 15)	CALA	Calithera Biosciences, Inc.	14.63	-1.59	-2.70	-3.80	Calithera Biosciences reports Q2 results [8/15/2022 4:15 PM]	4.47	0.34 (8.10%)	4.14	0.0 (0.00%)	2.30 - 49.80	214,966	110,000	1,120
Calithera Biosciences reports Q2 results [8/15/2022 4:15 PM] Calithera Biosciences Reports Second Quarter 2022 Financial Results and Recent Highlights [Aug-15-22 04:05PM] Calithera Biosciences (CALA) Q2 2022 Earnings Call Transcript [Aug-15-22 11:00PM]
10-05-2022	AH	4:05 PM ET (May 10)	CALA	Calithera Biosciences, Inc.	26.50	-0.18	-0.17	-0.28	Calithera Biosciences GAAP EPS of -$0.18 in-line [5/10/2022 4:20 PM]	0.1601	-0.04 (-21.79%)	0.21	0.0 (0.64%)	0.16 - 2.59	7,762,824	2,180,000	24,568
Calithera Biosciences GAAP EPS of -$0.18 in-line [5/10/2022 4:20 PM] Calithera Biosciences stock slips after PT cut at Ladenburg [5/11/2022 12:57 PM] Calithera Biosciences Reports First Quarter 2022 Financial Results and Recent Highlights [May-10-22 04:05PM]
31-03-2022	AH	4:05 PM ET (Mar 31)	CALA	Calithera Biosciences, Inc.	47.20	-0.24	-0.28	-0.32	Calithera Biosciences GAAP EPS of -$0.92 misses by $0.69 [3/31/2022 4:07 PM]	0.3672	-0.04 (-9.11%)	0.37	-0.03 (-7.55%)	0.35 - 2.59	4,848,650	3,340,000	139,732
Calithera Biosciences GAAP EPS of -$0.92 misses by $0.69 [3/31/2022 4:07 PM] Calithera stock falls 11% as Q4 net loss widens Y/Y [4/1/2022 10:43 AM] Calithera Biosciences Raises $10M Via Equity Issued At 10% Discount [Mar-30-22 11:24AM] Calithera Biosciences, Inc. Prices $10.0 Million Underwritten Public Offering of Common Stock and Warrants to Purchase Common Stock [Mar-30-22 02:00AM] Calithera Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Highlights [Mar-31-22 04:05PM] Calithera Biosciences (CALA) Q4 2021 Earnings Call Transcript [Apr-01-22 11:00AM]
09-11-2021	AH	4:05 PM ET (Nov 9)	CALA	Calithera Biosciences, Inc.	140.84	-0.15	-0.24	-0.32	Calithera Biosciences EPS beats by $0.08 [11/9/2021 4:31 PM]	0.8246	0.0 (0.55%)	0.83	0.01 (1.21%)	0.81 - 6.18	4,019,079	4,590,000	123,938
Calithera Biosciences EPS beats by $0.08 [11/9/2021 4:31 PM] Calithera Biosciences Reports Third Quarter 2021 Financial Results and Recent Highlights [Nov-09-21 04:05PM] Calithera Biosciences, Inc (CALA) Q3 2021 Earnings Call Transcript [Nov-10-21 08:31AM]
05-08-2021	AH	4:05 PM ET (Aug 5)	CALA	Calithera Biosciences, Inc.	151.06	-0.19	-0.23	-0.29	Calithera Biosciences EPS beats by $0.05 [8/5/2021 4:51 PM]	2.26	0.13 (6.10%)	2.08	-0.05 (-2.35%)	1.78 - 6.18	1,064,190	440,000	1,611
Calithera Biosciences Reports Second Quarter 2021 Financial Results and Recent Highlights [Aug-05-21 04:05PM] Calithera Biosciences, inc (CALA) Q2 2021 Earnings Call Transcript [Aug-06-21 09:01AM]
06-05-2021	AH	4:05 PM ET (May 6)	CALA	Calithera Biosciences, Inc.	152.54	-0.28	-0.27	-0.38	Calithera Biosciences EPS in-line [5/6/2021 4:45 PM]	2.09	0.01 (0.24%)	2.09	0.01 (0.48%)	2.03 - 7.34	781,158	660,000	518
Calithera Biosciences EPS in-line [5/6/2021 4:45 PM] Calithera Biosciences, Inc. to Host Earnings Call [May-06-21 02:45PM] Calithera Biosciences Reports First Quarter 2021 Financial Results and Recent Highlights [May-06-21 04:05PM] Calithera Biosciences Inc (CALA) Q1 2021 Earnings Call Transcript [May-07-21 03:30PM]
16-03-2021	AH	4:05 PM ET (Mar 16)	CALA	Calithera Biosciences, Inc.	203.91	-0.32	-0.32	-0.39	Calithera Biosciences EPS in-line [3/16/2021 4:12 PM]	2.90	0.04 (1.22%)	2.76	-0.10 (-3.50%)	2.38 - 8.18	833,679	943,601	14,555
Calithera Biosciences EPS in-line [3/16/2021 4:12 PM] Calithera Biosciences, Inc. to Host Earnings Call [Mar-16-21 02:45PM] Calithera Biosciences Reports Fourth Quarter 2020 Financial Results and Recent Highlights [Mar-16-21 04:06PM] Calithera Biosciences Inc (CALA) Q4 2020 Earnings Call Transcript [Mar-17-21 04:00AM]
05-11-2020	AH	4:05 PM ET (Nov 5)	CALA	Calithera Biosciences, Inc.	249.07	-0.32	-0.31	-0.38	Calithera Biosciences EPS misses by $0.01 [11/5/2020 5:07 PM]	3.90	0.16 (4.42%)	3.78	0.05 (1.34%)	2.99 - 8.18	638,366	350,696	17,943

10-08-2020	AH	4:05 PM ET (Aug 10)	CALA	Calithera Biosciences, Inc.	352.57	-0.29	-0.33	-0.58	Calithera Biosciences EPS beats by $0.05 [8/10/2020 4:21 PM]	4.29	-0.42 (-8.92%)	4.75	0.04 (0.85%)	2.45 - 8.18	560,421	778,910	675